ReWalk Robotics (NASDAQ:LFWD) Price Target Lowered to $4.00 at Lake Street Capital

ReWalk Robotics (NASDAQ:LFWD) had its price target dropped by research analysts at Lake Street Capital from $4.50 to $4.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Lake Street Capital’s price target would suggest a potential upside of 194.12% from the stock’s current price.

Several other analysts have also commented on the company. HC Wainwright reiterated a “buy” rating and set a $13.00 price objective on shares of ReWalk Robotics in a report on Tuesday. Laidlaw began coverage on ReWalk Robotics in a report on Monday, February 10th. They issued a “buy” rating and a $10.00 price target for the company.

ReWalk Robotics Price Performance

ReWalk Robotics stock traded up $0.05 during trading hours on Tuesday, reaching $1.36. The stock had a trading volume of 91,353 shares, compared to its average volume of 227,954. The company has a market cap of $14.46 million, a price-to-earnings ratio of -0.54 and a beta of 1.73. The business’s 50 day moving average price is $1.75 and its 200-day moving average price is $2.23. ReWalk Robotics has a 52 week low of $1.24 and a 52 week high of $6.00.

ReWalk Robotics (NASDAQ:LFWD) last posted its quarterly earnings data on Friday, March 7th. The company reported ($1.73) EPS for the quarter, missing the consensus estimate of ($0.20) by ($1.53). ReWalk Robotics had a negative return on equity of 43.02% and a negative net margin of 77.21%. The firm had revenue of $7.55 million for the quarter, compared to the consensus estimate of $7.30 million. On average, sell-side analysts forecast that ReWalk Robotics will post -1.78 EPS for the current fiscal year.

Insider Activity at ReWalk Robotics

In related news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $3.36, for a total value of $1,282,431.36. Following the sale, the insider now owns 1,049,430 shares in the company, valued at $3,526,084.80. This represents a 26.67 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.50% of the stock is owned by insiders.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.